One such molecule is DRP1 whose inhibitors i.e., Diethyl(3,4-dihydroxyphenethylamino) (quinolin-4-yl) methyl phosphonate (DDQ), mitochondrial division inhibitor 1 (Mdivi-1) and Dynasore have shown efficacy in preclinical studies in AD (Kandimalla et al., 2021; Medala et al., 2021). The gene discussed is DNM1L; the disease is Alzheimer disease.